| __timestamp | ACADIA Pharmaceuticals Inc. | Dyne Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 1145000000 |
| Thursday, January 1, 2015 | 76369000 | 2028000000 |
| Friday, January 1, 2016 | 4406000 | 2281000000 |
| Sunday, January 1, 2017 | 13060000 | 2932000000 |
| Monday, January 1, 2018 | 18330000 | 24000 |
| Tuesday, January 1, 2019 | 19598000 | 271000 |
| Wednesday, January 1, 2020 | 20550000 | 700000 |
| Friday, January 1, 2021 | 19141000 | 1088000 |
| Saturday, January 1, 2022 | 10166000 | 3345000 |
| Sunday, January 1, 2023 | 45731000 | 2461000 |
Data in motion
In the dynamic world of biotechnology, understanding cost structures is crucial. ACADIA Pharmaceuticals Inc. and Dyne Therapeutics, Inc. offer a fascinating comparison. Over the past decade, ACADIA's cost of revenue has fluctuated, peaking in 2015 with a 76% increase from the previous year. In contrast, Dyne Therapeutics experienced a dramatic 99% drop in 2018, highlighting the volatility in biotech operations.
This comparison underscores the importance of strategic financial planning in the biotech sector, where innovation and cost efficiency must go hand in hand.
Cost of Revenue: Key Insights for Novo Nordisk A/S and Dyne Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Amgen Inc. vs ACADIA Pharmaceuticals Inc.
Takeda Pharmaceutical Company Limited vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and ACADIA Pharmaceuticals Inc.
Bio-Techne Corporation vs Dyne Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Catalent, Inc. and ACADIA Pharmaceuticals Inc.'s Expenses
Cost of Revenue Trends: Catalent, Inc. vs Dyne Therapeutics, Inc.
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and Dyne Therapeutics, Inc.
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs Dyne Therapeutics, Inc.
Cost Insights: Breaking Down Pharming Group N.V. and Dyne Therapeutics, Inc.'s Expenses
Cost Insights: Breaking Down ADMA Biologics, Inc. and ACADIA Pharmaceuticals Inc.'s Expenses
Analyzing Cost of Revenue: ACADIA Pharmaceuticals Inc. and Xencor, Inc.